Elena A. Gorbatenko

Elena A. Gorbatenko

Auto-generated profile, based on publicly available information

Elena A. Gorbatenko

Tyumen Cardiology Research Center, Tomsk National Research Medical Center, Russian Academy of Sciences (Tyumen Cardiology Research Center, Tomsk NRMC)

Research Focus & Metrics

Academic Career Length

23Years (2004-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 January 2014 in Russian Journal of Cardiology
Verified
Journal Article
Open access
PDF file
VKV. A. Kuznetsov
V. A. Kuznetsov
EYE. I. Yaroslavskaya
E. I. Yaroslavskaya
GPG. S. Pushkarev
G. S. Pushkarev
IZI. P. Zyryanov
I. P. Zyryanov
IBIvan Bessonov
Ivan Bessonov
ANA. M. Nyamtsu
A. M. Nyamtsu
Цель. Выявить и оценить взаимосвязи между смертностью населения в Тюменской области и числом ЧКВ при ОКС в этом регионе в период с 2006 по 2012гг.Материал и методы. Использованы данные о количестве ЧКВ, представленные в ежегодных информационно-аналитических сборниках “Сердечно-сосудистая хирургия. Болезни и врожденные аномалии системы кровообращения”. Данные о смертности и заболеваемости опубликованы в статистических материалах департамента здравоохранения Тюменской области. Результаты. За изучаемый период на юге Тюменской области отмечалось прогрессивное снижение смертности населения и значительно увеличилось количество ЧКВ при ОКС. Была выявлена обратная корреляционная связь между количеством ЧКВ при ОКС и показателями общей смертности населения (r= –0,857, р=0,014), общей смертности среди трудоспособного населения (r= –0,893, р=0,007) и смертности населения от ССЗ (r= –0,857, р=0,014). Количество ЧКВ, выполняемых при ИМ оказалось связанным с общей смертностью (r= –0,929, p=0,003), общей смертностью среди трудоспособного населения (r= –0,964; р<0,001), смертностью от ИМ среди трудоспособного населения (r= –0,893; р=0,007) и среди мужчин трудоспособного населения (r= –0,893; р=0,007). Заключение. Наши данные подтверждают, что снижение сердечно-сосудистой смертности населения в Тюменской области во многом обусловлено прогрессивным увеличением с 2006 по 2012гг числа ЧКВ при острых формах ИБС.

28 February 2021 in Kardiologiia
Verified
Journal Article
Open access
PDF file
IBIvan Bessonov
Ivan Bessonov
VKV. A. Kuznetsov
V. A. Kuznetsov
EGE. A. Gorbatenko
E. A. Gorbatenko
ADA. O. Dyakova
A. O. Dyakova
SSS. S. Sapozhnikov
S. S. Sapozhnikov
Aim      To evaluate the effect of the total time of myocardial ischemia on results of the treatment of patients with ST segment elevation acute myocardial infarction (STEMI) who underwent percutaneous coronary interventions (PCI). Material and methods This study used data from a hospital register for PCI in STEMI from 2006 through 2017. 1649 patients were included. Group 1 consisted of 604 (36.6 %) patients with a total time of myocardial ischemia not exceeding 1880 min; group 2 included 531 (32.2 %) patients with a duration of myocardial ischemia from 180 to 360 min; and group 3 included 514 (31.2 %) patients with a duration of myocardial ischemia longer than 360 min. Results Mortality was lower in group 1 (2.3 %) than in groups 2 and 3 (6.2 and 7.2 %, respectively; p1–2=0.001; p1–3<0.001; p2–3=0.520). The incidence of major cardiac complications (“adverse cardiac events”, MACE) was lower in group 1 (4.1 %) than in groups 2 and 3 (7.3 and 9.5 %, respectively, p 1–2 =0.020; p 1–3 180 min were age (odd ratio, OR, 1.01 at 95 % confidence interval, CI, 1.0 to 1.02; р=0.044), female gender (OR, 1.64 at 95 % CI 1.26 to 2.13; р<0.001), chronic kidney disease (OR 1.82 at 95 % CI 1.21 to 2.74; р=0.004). Performing prehospital thrombolysis was associated with a decrease in the total time of myocardial ischemia (OR 0.4 at 95 % CI 0.31 to 0.51; р<0.001). A strong direct correlation was observed between the total time of myocardial ischemia and the time from the onset of pain syndrome to hospitalization (r=0.759; р180 min was associated with increased mortality and development of MACE. The total time of myocardial ischemia > 360 min was associated with increased incidence of the no-reflow phenomenon. The major predictors for the time of myocardial ischemia >180 min included age, female gender, and chronic kidney disease. The use of pharmacoinvasive strategy was associated with an increased number of patients with a total duration of myocardial ischemia <180 min. The contribution of the time of prehospital delay to the total time of myocardial ischemia was greater than the contribution of the “door-to-balloon” time. The time of prehospital delay showed a strong direct correlation with the total time of myocardial ischemia.

15 September 2020 in Kardiologiia
Verified
Journal Article
Closed access
PDF file
TGT. P. Gizatulina
T. P. Gizatulina
LML. U. Martyanova
L. U. Martyanova
TPT. I. Petelina
T. I. Petelina
EZE. V. Zueva
E. V. Zueva
NSN. E. Shirokov
N. E. Shirokov
EGE. A. Gorbatenko
E. A. Gorbatenko
Aim To study the relationship between the serum level of growth differentiation factor 15 (GDF-15) and clinical and functional characteristics and severity of left atrial (LA) fibrosis in patients with nonvalvular atrial fibrillation (AF). Material and methods The study included 87 patients with nonvalvular AF (62 patients with paroxysmal AF and 25 patients with persistent AF) aged 27 to 72 years (mean age, 56.9±9.2 years, 32 women). 85 % of these patients had arterial hypertension (AH), 33 % had AH and ischemic heart disease, and 12.6 % had isolated AF and were hospitalized for primary catheter ablation. General clinical evaluation, echocardiography, laboratory tests including measurement of GDF-15 and NT-proBNP concentrations in blood were performed. As a surrogate substrate of LA fibrosis during the electroanatomical voltage mapping, the area of low-voltage (20 %, statistically significantly different variables were included into a stepwise logistic regression analysis. Two independent predictors of LA fibrosis >20% were identified: a concentration of GDF-15 higher than median (odd ratio (OR), 3.318, 95 % confidence interval (CI): 1.184–9.298) and LA volume index (OR, 1.079, 95 % CI: 1.014–1.147). According to results of the ROC analysis, the area under the curve (AUC) was 0.762 (p=0.000), the model specificity was 72.3 %, sensitivity was 72.4 %, and the prediction accuracy was 72.4 %. Conclusion Blood levels of GDF-15 were associated with the presence and severity of major risk factors for AF and the area of LA fibrosis. In this study, a level of GDF-15 above the median and the LA volume index were independent predictors of LA fibrosis > 20% of the LA area.

29 April 2021 in Siberian Scientific Medical Journal
Verified
Journal Article
Open access
PDF file
IBIvan Bessonov
Ivan Bessonov
VKV. A. Kuznetsov
V. A. Kuznetsov
EGE. A. Gorbatenko
E. A. Gorbatenko
SSS. S. Sapozhnikov
S. S. Sapozhnikov
IZI. P. Zyryanov
I. P. Zyryanov
Given the global trend of population aging, it is natural to see an increase in the number of percutaneous coronary interventions (PCI) performed in patients of older age groups.The aim of this study was to compare the results of percutaneous coronary interventions (PCI) in different age groups and find a predictors of hospital mortality. Methods. Data were collected from 1649 patients with STEMI who were admitted to the coronary care unit and underwent PCIs from2006 to 2017. Patients were divided into 3 age groups according to World Heals Organization classification. The first group consisted of 850 patients aged from 18 to 59 years, the second group consisted 620 patients aged from 60 to 74 years, and third group consisted of 179 patients aged from 75 years and older. Results. The rate of in-hospital death was statistically significant lower in younger groups (groups 1-2: 2.2 % vs 5.8 %, р<0.001; groups 1-3: 2.2 % vs 16.2 %, р<0.001; 2-3: 5.8 % vs 16.2 %, р<0.001). After multivariate adjustment the independent predictor of death were age (odds ratio (OR) =1.08; 95 % confidence interval (CI) 1.05-1.11, р<0.001), anterior myocardial infarction (OR=2.03; 95 % CI 1.15-3.59, р=0.015), Syntax score (OR=1.05; 95 % CI 1.02-1.09, р=0.001), ventricular arrhythmias (OR=4.98; 95 % CI 2.49-9.96, р<0.001), blood glucose level at admission (OR=1.06; 95 % CI 1.01-1.13, р=0.040), PCI failure (OR=5.05; 95 % CI 2.47-10.3, р<0.001), Killip class III-IV (OR=6.01; 95 % CI 3.12–11.6, р180 minutes (OR=4.39; 95 % CI 1.78-10.8, р=0.001). Conclusions. PCIs for STEMI in older age groups were associated with worse in-hospital outcomes. Age, anterior myocardial infarction, Syntax score, ventricular arrhythmias, blood glucose level at admission, PCI failure, Killip class III-IV, total ischemia time >180 minutes were the independent predictor of death.

6 November 2020 in Patologiya krovoobrashcheniya i kardiokhirurgiya
Verified
Journal Article
Open access
PDF file
IBIvan Bessonov
Ivan Bessonov
VKV. Kuznetsov
V. Kuznetsov
ЕГЕ. А. Горбатенко
Е. А. Горбатенко
ССС. С. Сапожников
С. С. Сапожников
ADA. Dyakova
A. Dyakova
АДА. О. Дьякова
А. О. Дьякова
Background. No-reflow phenomenon during primary percutaneous coronary intervention (PCI) is a significant clinical problem in patients with ST-elevation myocardial infarction (STEMI), and its predictors remain unclear.Aim. To develop a scoring system to predict the risk of no-reflow in patients undergoing PCI for STEMI.Methods. Data were collected from 1280 consecutive patients with STEMI (59.2±11.4 years, 74.2% men, 5.2% no-reflow) who were admitted to the coronary care unit and underwent PCI. Baseline clinical, angiographic and procedural variables were used to develop the risk score in a training dataset (n=888, 70%) which was then validated in a test dataset (n=392, 30%). A credit risk assessment tool was used to construct a precise screening tool for no-reflow.Results. The model comprised age, pain to revascularisation time, neutrophil count, admission plasma glucose level, initial TIMI flow and direct stenting as the only independent predictors of no-reflow. These factors were weighted and used to develop a risk score ranging from 0 to 7. In the training dataset, the optimal threshold score for predicting no-reflow was ≥35, with 69% sensitivity and 81% specificity (area under the curve (AUC) = 0.84, p < 0.001). When these findings were applied to the test dataset, the AUC was 0.75 (p < 0.001), with 70% sensitivity and 80% specificity.Conclusion. The score developed in this study, based on clinical, angiographic and procedural features, can be used with acceptable accuracy to predict no-reflow in STEMI patients treated by PCI. Received 29 August 2019. Revised 25 March 2020. Accepted 16 April 2020. Funding: The study did not have sponsorship. Conflict of interest: Authors declare no conflict of interest.

31 July 2021 in Kardiologiia
Verified
Journal Article
Open access
PDF file
TGT. P. Gizatulina
T. P. Gizatulina
NKN. Yu. Khorkova
N. Yu. Khorkova
LML. U. Martyanova
L. U. Martyanova
TPT. I. Petelina
T. I. Petelina
EZE. V. Zueva
E. V. Zueva
EGE. A. Gorbatenko
E. A. Gorbatenko
Aim To study the role of blood concentration of growth differentiation factor 15 (GDF-15) as a predictor of left atrial/left atrial appendage (LA/LAA) thrombosis in patients with nonvalvular atrial fibrillation (AF). Material and methods 538 patients with nonvalvular AF were admitted to the Tyumen Cardiology Research Center in 2019–2020 for radiofrequency ablation and elective cardioversion. According to findings of transesophageal echocardiography (EcoCG), 42 (7.8%) of these patients had LA/LAA thrombosis and 79 (14.7%) of them had the effect of spontaneous echo contrast (SEC). This comparative, cross-sectional, cohort study included at the initial stage 158 successively hospitalized patients with nonvalvular AF: group 1 (with LA/LAA thrombosis, n=42) and group 2 (without LA/LAA thrombosis and without SEC, n=116). To eliminate significant differences in age between the groups, an additional inclusion criterium was introduced, age from 45 to 75 years. Finally, 144 patients were included into the study: group 1 (with LA/LAA thrombosis, n=42, mean age 60.9±7.2 years) and group 2 (without LA/LAA thrombosis and without SEC, n=116, mean age 59.5±6.0 years). 93 (91%) patients in group 1 and 40 (95%) patients in group 2 had arterial hypertension (p=0.4168); 53 (52%) and 29 (^(%), respectively, had ischemic heart disease (p=0.0611). The groups did not differ in sex, profile of major cardiovascular diseases, or frequency and range of oral anticoagulant treatment. General clinical evaluation, EchoCG, and laboratory tests, including measurements of blood concentrations of GDF-15 and NT-proBNP, were performed. Results In the group with LA/LAA thrombosis, 1) persistent AF prevailed whereas paroxysmal AF was more frequently observed in patients without thrombosis; 2) a tendency toward more pronounced chronic heart failure was observed; 3) tendencies toward a high median CHA2DS2‑VASc score and toward a greater proportion of patients with scores ≥3 were observed. According to EchoCG findings, group 1 had higher values of sizes and volumes of both atria and the right ventricle, left ventricular (LV) end-systolic volume and size, pulmonary artery systolic blood pressure, and LV myocardial mass index. LV ejection fraction (EF) was in the normal range in both groups but it was significantly lower for patients with LA/LAA thrombosis, 59.1±5.1 and 64.0±7.3, respectively (p=0.00006). Concentrations of GDF-15 (p=0.00025) and NT-proBNP were significantly higher in group 1 than in group 2 (p=0.000001). After determining the threshold values for both biomarkers using the ROC analysis, two independent predictors of LA/LAA thrombosis were obtained by the stepwise multiple regression analysis: GDF-15 >935.0 pg/ml (OR=4.132, 95 % CI 1.305–13.084) and LV EF (OR=0.859, 95 % CI 0.776–0.951). The ROC analysis assessed the model quality as good: AUC=0.776 (p935.0 pg/ml) and LV EF are independent predictors for LA/LAA thrombosis.